Akari Therapeutics PLC
F:CLA
Akari Therapeutics PLC
F:CLA
Price:
0.0556
EUR
Market Closed
Market Cap:
€198.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Akari Therapeutics PLC
F:CLA
|
US |
|
R
|
Relx PLC
XMUN:RDEB
|
UK |
|
P
|
PetroChina Co Ltd
XMUN:PC6
|
CN |
|
Paladin Energy Ltd
TSX:PDN
|
AU |
|
Lument Finance Trust Inc
F:70X
|
US |
|
Maeda Kosen Co Ltd
TSE:7821
|
JP |
|
N
|
Nippon Telegraph and Telephone Corp
F:NTT
|
JP |
|
T
|
Tupperware Brands Corp
SWB:TUP
|
US |
|
Ageas SA
OTC:AGESF
|
BE |
Wall St Price Targets
CLA Price Targets Summary
Akari Therapeutics PLC
Akari Therapeutics PLC
Wall Street analysts forecast CLA stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for CLA is 0.2399 EUR with a low forecast of 0.1799 EUR and a high forecast of 0.277 EUR.
Lowest Forecast
Price Target
0.1799
EUR
223% Upside
Average Forecast
Price Target
0.2399
EUR
332% Upside
Highest Forecast
Price Target
0.277
EUR
398% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CLA's stock price target?
Price Target
0.2399
EUR
0.2399
EUR
According to Wall Street analysts, the average 1-year price target for CLA is 0.2399 EUR with a low forecast of 0.1799 EUR and a high forecast of 0.277 EUR.
